Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States.

Shebl FM, Bhatia K, Engels EA.

Int J Cancer. 2010 May 15;126(10):2503-8. doi: 10.1002/ijc.24930.

2.

Increased risk of stomach and esophageal malignancies in people with AIDS.

Persson EC, Shiels MS, Dawsey SM, Bhatia K, Anderson LA, Engels EA.

Gastroenterology. 2012 Oct;143(4):943-950.e2. doi: 10.1053/j.gastro.2012.07.013. Epub 2012 Jul 14. Retraction in: Gastroenterology. 2016 Apr;150(4):1048.

3.

The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States.

Sahasrabuddhe VV, Shiels MS, McGlynn KA, Engels EA.

Cancer. 2012 Dec 15;118(24):6226-33. doi: 10.1002/cncr.27694. Epub 2012 Jun 26.

4.

Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States.

Lanoy E, Dores GM, Madeleine MM, Toro JR, Fraumeni JF Jr, Engels EA.

AIDS. 2009 Jan 28;23(3):385-93. doi: 10.1097/QAD.0b013e3283213046.

5.

Risk of human papillomavirus-associated cancers among persons with AIDS.

Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA.

J Natl Cancer Inst. 2009 Aug 19;101(16):1120-30. doi: 10.1093/jnci/djp205. Epub 2009 Jul 31.

7.

Long-term cancer risk among people diagnosed with AIDS during childhood.

Simard EP, Shiels MS, Bhatia K, Engels EA.

Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):148-54. doi: 10.1158/1055-9965.EPI-11-0823. Epub 2011 Nov 8.

8.

Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States.

Guech-Ongey M, Engels EA, Goedert JJ, Biggar RJ, Mbulaiteye SM.

Int J Cancer. 2008 Jun 1;122(11):2590-3. doi: 10.1002/ijc.23384.

9.

Seroreactivity against Epstein-Barr virus (EBV) among first-degree relatives of sporadic EBV-associated nasopharyngeal carcinoma in Indonesia.

Hutajulu SH, Ng N, Jati BR, Fachiroh J, Herdini C, Hariwiyanto B, Haryana SM, Middeldorp JM.

J Med Virol. 2012 May;84(5):768-76. doi: 10.1002/jmv.23263.

PMID:
22431025
10.

Association of cancer with AIDS-related immunosuppression in adults.

Frisch M, Biggar RJ, Engels EA, Goedert JJ; AIDS-Cancer Match Registry Study Group.

JAMA. 2001 Apr 4;285(13):1736-45.

PMID:
11277828
11.

Can Epstein-Barr virus infection be the primary etiological factor to nasopharyngeal carcinoma?

Lin Y, Zhang J, Liu S.

Med Hypotheses. 2010 May;74(5):956-7. doi: 10.1016/j.mehy.2009.11.040. Epub 2009 Dec 29. No abstract available.

PMID:
20042298
12.

Detection of Epstein-Barr virus in metastatic lymph nodes of patients with nasopharyngeal carcinoma and a primary unknown carcinoma.

Nakao K, Yuge T, Mochiki M, Nibu K, Sugasawa M.

Arch Otolaryngol Head Neck Surg. 2003 Mar;129(3):338-40.

PMID:
12622545
13.

Cancer risk in people infected with human immunodeficiency virus in the United States.

Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ.

Int J Cancer. 2008 Jul 1;123(1):187-94. doi: 10.1002/ijc.23487.

14.

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort.

J Natl Cancer Inst. 2005 Mar 16;97(6):425-32.

15.

Spectrum of cancer risk among US solid organ transplant recipients.

Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M.

JAMA. 2011 Nov 2;306(17):1891-901. doi: 10.1001/jama.2011.1592.

17.

An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and Epstein-Barr virus activation.

Xu FH, Xiong D, Xu YF, Cao SM, Xue WQ, Qin HD, Liu WS, Cao JY, Zhang Y, Feng QS, Chen LZ, Li MZ, Liu ZW, Liu Q, Hong MH, Shugart YY, Zeng YX, Zeng MS, Jia WH.

J Natl Cancer Inst. 2012 Sep 19;104(18):1396-410. Epub 2012 Sep 12.

18.

Second malignant tumors in patients with nasopharyngeal carcinoma and their association with Epstein-Barr virus.

Wang CC, Chen ML, Hsu KH, Lee SP, Chen TC, Chang YS, Tsang NM, Hong JH.

Int J Cancer. 2000 Jul 15;87(2):228-31.

19.

Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families.

Yu KJ, Hsu WL, Pfeiffer RM, Chiang CJ, Wang CP, Lou PJ, Cheng YJ, Gravitt P, Diehl SR, Goldstein AM, Chen CJ, Hildesheim A.

Clin Cancer Res. 2011 Apr 1;17(7):1906-14. doi: 10.1158/1078-0432.CCR-10-1681. Epub 2011 Mar 29.

20.

Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population.

Dogan S, Hedberg ML, Ferris RL, Rath TJ, Assaad AM, Chiosea SI.

Head Neck. 2014 Apr;36(4):511-6. doi: 10.1002/hed.23318. Epub 2013 Jun 18.

Items per page

Supplemental Content

Write to the Help Desk